Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board approved audited results for Q4 FY25 and the full year ended March 31, 2025. Full-year revenue from operations jumped sharply to Rs. 3,027.60 lakhs from Rs. 128.13 lakhs last year, driven by agricultural commodity trading. However, net profit for the year fell to Rs. 8.88 lakhs (vs Rs. 14.17 lakhs), and the standalone Q4 alone slipped into a loss of Rs. 59.92 lakhs versus a small profit a year ago, as costs rose disproportionately. The company also raised Rs. 58.60 crores through 9 crore convertible warrants (fully received, used for working capital), which substantially strengthened the balance sheet — Other Equity swung from negative Rs. 18.54 lakhs to Rs. 5,850.33 lakhs. The statutory auditor (VSSB & Associates) issued an unmodified (clean) opinion. Operating cash flow for the year was deeply negative at Rs. (2,820.47) lakhs due to a sharp build-up in inventory (Rs. 1,646.63 lakhs) and short-term loans and advances (Rs. 3,039.46 lakhs). The company confirmed it is not classified as a Large Corporate, with total borrowings of just Rs. 29.34 lakhs.
Mixed picture for shareholders: headline revenue surged over 20x but profitability and Q4 performance deteriorated, and operating cash burn is a red flag despite a clean audit. The Rs. 58.6 crore warrant infusion strengthens the balance sheet and provides working-capital headroom, which may support future growth, but margin compression and cash-flow quality warrant close monitoring.